close search

Stellabody® technology

Burnet’s Stellabody® technology exploits a natural antibody behaviour to facilitate the formation of hexamers. This enhances the action of antibodies and related biologics.

Our Immune Therapies group is an internationally recognised laboratory in antibody immune function and has significant expertise to transform antibody assets into a potent and efficacious therapeutic for treating cancer, autoimmune disease and infection.

About Stellabody®

This flyer contains information about:

  • Stellabody® technology’s on-target hexamerisation
  • our Immune Therapies group’s capabilities
  • fee-for-service work.

Download Stellabody® flyer (PDF 270 KB)